Pfizer Inc. today announced that the federal government has agreed to purchase an additional 200 million doses of its COVID-19 vaccine. The deal raises the total number of doses to be supplied to the U.S. government under its existing supply agreement to 500 million and includes an option to acquire an updated version of the vaccine to address potential variants as well as new formulations of the vaccine, if available and authorized.

Related News Articles

Headline
Moderna today announced the completion of its biologic license application to the Food and Drug Administration for its mRNA COVID-19 vaccine. The application…
Headline
The AHA today released new public service announcements and related digital content encouraging vaccination against COVID-19 by still-unvaccinated health care…
Headline
The Centers for Disease Control and Prevention today released research highlighting two important trends emerging from the COVID-19 pandemic regarding vaccines…
Headline
The Food and Drug Administration today granted full approval for the Pfizer-BioNTech COVID-19 vaccine for individuals age 16 and over. The vaccine, which will…
Perspective
As of now, most school districts have opened or plan to reopen this month or next, so the return to in-person schooling is underway. Many kids — not to mention…
Headline
In a federally funded study that enrolled more than 500 patients from U.S. hospital emergency departments, administering COVID-19 convalescent plasma to high-…